End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 CNY | +0.08% | -3.44% | -45.13% |
Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Business Summary
Number of employees: 2,388
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Autonomous Vaccine
99.1
%
| - | - | 4,078 | 99.1 % | - |
Intermediate Products
0.4
%
| 27 | 0.5 % | 17 | 0.4 % | -36.61% |
Technical Services
0.3
%
| 17 | 0.3 % | 11 | 0.3 % | -33.40% |
Other Business
0.2
%
| 8 | 0.2 % | 8 | 0.2 % | +3.51% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
93.0
%
| 4,803 | 94.4 % | 3,826 | 93.0 % | -20.34% |
Overseas
7.0
%
| 283 | 5.6 % | 288 | 7.0 % | +1.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Run Sheng Jiang
PSD | President | 67 | 16-06-21 |
Hua Zhou
DFI | Director of Finance/CFO | 57 | 14-06-22 |
Shao zhong Dong
BRD | Director/Board Member | 56 | 22-01-26 |
Jian Kang Zhang
BRD | Director/Board Member | 66 | 20-05-28 |
Zhen Huang
BRD | Director/Board Member | 61 | 02-12-31 |
Yu Ran Liu
SEC | Corporate Secretary | 35 | 22-11-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ling Bing Zeng
BRD | Director/Board Member | 67 | 22-10-12 |
Zhen Huang
BRD | Director/Board Member | 61 | 02-12-31 |
Yun Chun Li
CHM | Chairman | 62 | 09-06-22 |
Jin Yu Zhu
BRD | Director/Board Member | 57 | 09-06-22 |
Yun Geng
BRD | Director/Board Member | 27 | 22-10-12 |
Run Sheng Jiang
PSD | President | 67 | 16-06-21 |
Gang Hong Sun
BRD | Director/Board Member | 55 | 22-10-12 |
Yong Wu Fan
BRD | Director/Board Member | 52 | 20-08-11 |
Jian Mei Zhao
BRD | Director/Board Member | 55 | 20-10-11 |
Ting Yan
BRD | Director/Board Member | 37 | 21-11-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,613,348,427 | 1,376,761,070 ( 85.34 %) | 7,999,943 ( 0.4959 %) | 85.34 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
9,999,943 | 0.64% | 20,313,384 $ | |
37,560,998 | 7.33% | 6,002,999 $ |
Company contact information
Walvax Biotechnology Co., Ltd.
395, Kexin Road High-tech Zone
650101, Kunming
+86 87 1683 30860
http://www.walvax.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.13% | 2.84B | |
+1.17% | 91.72B | |
0.00% | 39.44B | |
-8.52% | 34.47B | |
+64.13% | 26.7B | |
-17.37% | 15.13B | |
-5.99% | 13.27B | |
-10.69% | 11.74B | |
-47.78% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- 300142 Stock
- Company Walvax Biotechnology Co., Ltd.